机构地区:[1]解放军第九七医院特诊科,江苏徐州221004 [2]解放军第九七医院消化内科,江苏徐州221004 [3]解放军第九七医院生物治疗中心,江苏徐州221004
出 处:《现代肿瘤医学》2016年第1期19-23,共5页Journal of Modern Oncology
基 金:全军医药卫生科研基金(编号:11MA040)
摘 要:目的:探讨树突状细胞(DC)荷载α-半乳糖神经酰胺(α-GalCer)联合肿瘤特异性细胞毒T淋巴细胞(CTL)对小鼠Heps肝癌移植瘤生长的抑制作用。方法:诱导扩增小鼠骨髓来源的DC细胞和T淋巴细胞,培养成为具有肿瘤特异性的CTL,DC细胞体外荷载α-GalCer。建立Heps肝癌移植瘤模型,将36只模型鼠随机分为4组(n=9),分别尾静脉给予生理盐水(对照组)、CTL(CTL组)、DC荷载α-GalCer(DC荷载α-GalCer组)、DC细胞荷载α-GalCer+CTL(联合治疗组)输注。每隔两天测量移植瘤体积,观察体积变化。于治疗后第14d,处死小鼠,取眼球血及瘤体组织。流式细胞术(FCM)检测外周血CD4^+、CD8^+T细胞比例。免疫组织化学染色观察肿瘤组织中Bcl-2/Bax凋亡蛋白的表达。结果:与对照组相比,各治疗组均可抑制肿瘤的生长,差异具有统计学意义(P<0.01);联合治疗组较DC荷载α-GalCer组及CTL组肿瘤体积明显减小(P<0.05)。联合治疗组小鼠外周血CD4^+、CD8^+T细胞数量较另外三组显著升高(P<0.05);对照组、CTL组、DC荷载α-GalCer组小鼠外周血中CD4^+、CD8^+T细胞含量无明显差异(P>0.05)。与对照组相比,各治疗组移植瘤内Bax阳性细胞数量明显增加(P<0.05),Bcl-2阳性细胞数量明显减少(P<0.05);与CTL组和α-GalCer组相比,联合治疗组移植瘤内Bax阳性细胞明显增加(P<0.05),Bcl-2阳性细胞明显下降(P<0.05)。结论:DC荷载α-GalCer与肿瘤特异性CTL联合应用能够对小鼠Heps肝癌移植瘤具有协同杀伤作用。Objective: To investigate the inhibitory effects of dendritic cells(DC) load alpha - Galactosylceramide ( α- GalCer) combined with tumor specific cytotoxic T lymphocyte(CTL) on the growth of transplanted Heps hepatoma in mice. Methods:Induce the DC cells and T lymphocyte that expanded the mice bone marrow, making it become a tumor specific CTL. DC cells load α- GalCer. First establish Heps liver cancer xenograft model, then randomly divide the 36 model mice into 4 groups (n = 9 ) , and respectively intravenous inject physiological saline (control group) , eytotoxie T lymphocyte( CTL group), DC load α -GalCer( DC load α -GalCer group) and DC load α -GalCer combined with cytotoxic T lymphocyte (combined treatment group). Measuring the volume of tumor at two days, observing the change of volume. In the fourteenth days after treatment, randomly selected from each group of 9 mices were sacrificed to obtain the ocular blood, spleen and tumor tissue in mice : Using flow cytometry detect the proportion of peripheral blood CD4+ , CD8 + T cells. Immunohistochemical staining was performed in the sections for Bcl -2 and Bax to count Bcl - 2 positive cells and Bax positive cells in the local tumor. Results : The tumor average volume and weight in the control group was higher than in the CTL group, DC loading α - GalCer group and the combined treatment group ( P 〈 0.01 ). The average volume of the tumors in the combined treatment groups was significantly reduced than in the CTL group and DC loading α -GalCer group(P 〈0.05). On day 14 after treatment,the CD4+ ,CD8 + T lymphocyte in the combined treatment group was significantly increased than in the control group, CTL group and DC loading α - GalCer group(P 〈0.05 ). And the CD4+ , CD8+ T lymphocyte was no obvious difference in the control group, CTL group and the DC loading α - GalCer group( P 〉 0.05 ). The number of BAX positive cells in transplanted tumor were significantly increased (P 〈
关 键 词:α-半乳糖神经酰胺 DC 肿瘤特异性细胞毒T淋巴细胞 自然杀伤T细胞 Heps肝癌
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...